Summa Equity acquires majority stake in SG-based biotech firm Sengenics

Summa Equity acquires majority stake in SG-based biotech firm Sengenics

15 October, 2020

Printed by Unregistered user on Mon, 08 Dec 2025 00:11:07 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Singapore's GIC increases stake in Chinese used-car platform Uxin to 11.4%

Singapore's GIC invests in US-based self-storage player StorageMart

Read more from Singapore

Editor’s Picks: The Week That Was Dec 1 – 6

Venture Capital

SG’s Docquity raises $3m in second tranche of Series C1 funding